Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of Safety and Effectiveness of an IOL With a Virtual Aperture Optic

NCT: NCT05955846 · RECRUITING

NCT IDNCT05955846
StatusRECRUITING
Start Date2025-08-07
Completion2027-09
SponsorZ Optics, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

Cataracts are cloudy areas in the lens of the eye that can cause changes in vision. Symptoms of cataracts include cloudy or fuzzy vision and sensitivity to glare. Cataract extraction with Intraocular lens (IOL) implantation is the most commonly performed surgical procedure in the world. Presbyopia affects almost everyone over the age of 50. With age, the natural crystalline lens loses its ability to change shape, or accommodate, to focus on near distances. Thus, individuals with excellent distance vision will still need to wear spectacles for near tasks such as reading, and intermediate tasks such as computer work.

Frequently Asked Questions

What is Evaluation of Safety and Effectiveness of an IOL With a Virtual Aperture Optic?

Evaluation of Safety and Effectiveness of an IOL With a Virtual Aperture Optic is a clinical trial registered under NCT05955846. Current status: RECRUITING.

What is the status of NCT05955846?

The current status of NCT05955846 (Evaluation of Safety and Effectiveness of an IOL With a Virtual Aperture Optic) is: RECRUITING.

When did Evaluation of Safety and Effectiveness of an IOL With a Virtual Aperture Optic start?

Evaluation of Safety and Effectiveness of an IOL With a Virtual Aperture Optic started on 2025-08-07.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.